Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Effects of AkPharma's Calcium Glycerophosphate Nasal Spray Wash

This study has been completed.
AkPharma Inc.
Information provided by (Responsible Party):
Edward Schulman, Drexel University Identifier:
First received: July 19, 2012
Last updated: May 21, 2015
Last verified: May 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2015
  Primary Completion Date: April 2015 (Final data collection date for primary outcome measure)